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Human colon cancer line SW480
Apoptosis
MitochondriaABSTRACT
Objective: To investigate the anti-proliferation effect and mechanism of zoledronic acid
(ZOL) on human colon cancer line SW480.
Methods: SW480 cells were treated with 0, 12.5, 25, 50, 100 and 200 mmoL/L of ZOL
for 48 h, and CCK-8 assay was employed to obtain the survival rate of SW480 cells.
SW480 cells were treated with 25 mmoL/L of ZOL for 0, 12, 24, 48 and 72 h, and then the
survival rate was obtained. SW480 cells of the ZOL group were treated with 25 mmoL/L
of ZOL for 48 h, while cells of the CsA + ZOL group were pretreated with 10 mmoL/L of
CsA for 0.5 h and then treated with 25 mmoL/L of ZOL for 48 h. Then the survival rates
of SW480 cells of the control group, ZOL group and CsA + ZOL group were determined.
Flow cytometry was employed to detect the apoptosis rate and the mitochondrial trans-
membrane potential (△Jm) of the three groups and Western blot was used to detect the
expressions of cyt C in the cytosol of the three groups.
Results: ZOL inhibited the proliferation of SW480 cells, and the inhibition rate posi-
tively correlated with the concentration of ZOL and the action time (P < 0.01). The cell
survival rate and the △Jm of the ZOL group were greatly lower than those of the
control group, while the apoptosis rate and the expression of cyt C in the cytosol were
obviously higher than those of the control group. All the differences showed distinctly
statistical signiﬁcances (P < 0.01). The cell survival rate and the △Jm of the
CsA + ZOL group were all lower than those of the control group, but substantially higher
than those of the ZOL group; while the apoptosis rate and the expression of cyt C in the
cytosol were higher than those of the control group, but distinctly lower than those of the
ZOL group. All the differences were statistically signiﬁcant (P < 0.01).
Conclusions: ZOL can induce the apoptosis in human colon cancer line SW480 and then
inhibit the proliferation of SW480 cells directly by opening the mitochondrial permeability
transition pore abnormally, decreasing△Jm, and releasing the cyt C into the cytosol. And
the effect enhances with the increases of the concentration of ZOL and the action time.1. Introduction
In recent years, the transformation to delicate diet structure
and intensive life style cause rapidly increase of colorectalcancer morbidity by nearly 5% every year, which far exceeds
2% of the international average standard [1]. The latest
investigation report on cancer epidemiology showed that the
morbidity and mortality rates of colorectal cancer in 2010 in
our country reached 16.14% and 7.55%. Among them, most
patients were males. The morbidity and mortality of male
patients were 18.75% and 9.10%, respectively [2]. Colorectal
cancer has obviously become one of the most dangerous
killers for human health which severely threatens people's life
and health. The grim situation has set off an alarm bell for
medical workers to attach importance to the treatment research
of the disease. As the newest nitrogen-containingCC BY-NC-ND license (http://
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zoledronic acid (ZOL) increases by 2000 times as compared to
that of the ﬂexor chloride sodium phosphate and reaches the 200
times of that of pamidronate [3], which is widely employed to
prevent and treat solid tumor bone metastases and delay the
development of the cancer-caused bone damage. In the further
clinical experiences, it is proved that ZOL can not only prevent
bone diseases, but also have effects on the cancer activity which
can inhibit the proliferation and reduce the activity of cancer
cells. However, researches on effects of ZOL were mainly on
diseases, such as breast cancer, prostate cancer, squamous-cell
carcinoma and so on [4–6]. There are few researches on the
effects of ZOL on colorectal cancer. Therefore, the study aims
to propose a new development direction for the treatment of
colorectal cancer by investigating the anti-proliferation effect
and mechanism of ZOL on human colon cancer line SW480, and
now it is reported as follows.
2. Materials and methods
2.1. Cell lines, experimental materials and methods
Six concentration levels of ZOL were established and every
level was treated with three holes parallel sample for subculture
until the concentration of the logarithmic phase of SW480
(Shanghai Cells of Chinese Academy of Sciences) became
2 × 104/mL after digestion and dilution. They were placed on
96-well plates with 0.1 mL/well for anchorage growth under a
suitable environment. After 24 h, the medium was changed into
a fresh medium which had ZOL (Novartis Co. Ltd, Switzerland)
and the concentrations of ZOL of each hole were 0, 12.5, 25, 50,
100 and 200 mmoL/L. After 48 h of the inﬁltration with ZOL,
0.01 mL of CCK-8 reagent (Shanghai LI Rui Biotechnology
Co., Ltd.) was added along the hole wall into each hole. The
reagent and the medium were mixed by taping the culture plate.
After 4 h of full reaction, the light absorption values at 450 nm
of each group were detected. The experience was conducted
three times to investigate the effects of ZOL on anti-proliferation
of SW480 in different concentrations.
Five time levels were established and meanwhile parallel
sample with three holes in each level was treated. SW480 cells
in the logarithmic phase with the concentration of 2 × 104 mL
were cultured on 96-well plates with 0.1 mL/well. After adherent
culture, the medium was changed into a fresh medium and then
they were continuously cultured for 72 h. Then in the corre-
sponding time points, 25 mmoL/L of ZOL was added into them.
After ZOL was inﬁltrated for 0, 12, 24, 48 and 72 h, CCK-8
reagent was added. After 4 h of full reaction, the light absorp-
tion values at 450 nm of each group were detected. The expe-
rience was conducted three times to investigate the effects of
ZOL on anti-proliferation of SW480 in different time periods.
Three control groups were formed and meanwhile parallel
sample with three holes was treated. SW480 cell suspension
with the concentration of 4 × 105/mL was inoculated on 6-well
plates for anchorage growth under a suitable environment. After
24 h, the medium of the CsA + ZOL group was changed into a
fresh medium which contained 10 mmol/L of cyclosporine A for
pretreatment. The media of the control and the ZOL groups were
changed into equal number of fresh media. After CsA had
inﬁltrated 0.5 h, 25 mmoL/L of ZOL was respectively added into
the ZOL and CsA + ZOL groups. The three groups were
continuously cultured for 48 h, and then they were proceeded asfollows:① 0.01 mL of CCK-8 reagent was added along the hole
wall into each hole. After 4 h of full reaction, the cell activity
was tested in the light of the CCK-8 kit instruction to study the
differences of the survival rate of SW480 cells; ② cells treated
with digestion, washing, dilution and other operations were
collected and their apoptosis rates were determined by FACS-
Calibu ﬂow cytometry (BD Company, USA);③ suspensions of
each group which had made form cell's digestion and washing
were collected and fully mixed with 1 mmoL/L of JC-1
(Shanghai Yisheng Biotechnology Co., Ltd.). Then after
shading cultivation for 20 min, cells were collected by centri-
fugation. After washing and diluting many times, the ﬂuores-
cence intensity was detected by ﬂow cytometry to investigate the
difference of the mitochondrial transmembrane potential
(△Jm); ④ cells after homogenate of each group were centri-
fuged at 12000 g for 15 min at 4 C. Then, the supernatant was
collected and its expression quantity of cyt C was tested by
Western Blot to investigate the differences of the content of cyt
C in the cytosol in each group.
2.2. Statistical methods
SPSS 19.0 was used for statistical analysis. Cell survival rate,
apoptosis rate,△Jm, and the protein content of cyt C were all
represented with mean ± SD. As for the data of the cell survival
rates which were treated with ZOL in different concentration
levels and time levels, ANOVA was used to analyze multi-group
comparison and SNK-q was used to test comparison between
two groups. As for the data of the control groups, comparison
between two groups was tested by t-test. P < 0.05 showed
statistical signiﬁcance.
3. Results
3.1. Dose-dependent effects of zoledronic acid on
SW480 cell survival rate
The cell survival rate which had detected in the concentration
of 0 mmoL/L of ZOL was regarded as the reference standard.
The cell survival rates of SW480 cells which were treated with
12.5, 25, 50, 100 and 200 mmol/L of ZOL for 48 h dropped to
(64.23 ± 3.23)%, (51.88 ± 3.06)%, (44.81 ± 2.93)%,
(39.28 ± 2.67)% and (30.24 ± 3.34)% respectively. With the
increase in the inﬁltrating concentration of ZOL, the survival
rates of SW480 in its different concentration levels decreased
step by step, and the comparison differences had distinctly sta-
tistical signiﬁcances (P < 0.01). Compared with the untreated
group, cell survival rates of SW480 cells in the different con-
centration levels of ZOL were signiﬁcantly lower. Also, the
comparison differences had distinctly statistical signiﬁcances
(P < 0.01) (Table 1).
3.2. Time-dependent effects of zoledronic acid on
SW480 cell survival rate
The cell survival rate of ZOL which had detected after
inﬁltrating for 0 h was regarded as the reference standard. The
cell survival rates of SW480 cells which were respectively
treated with 200 mmol/L of ZOL for 12, 24, 48 and 72 h dropped
to (90.77 ± 2.82)%, (73.38 ± 2.49)%, (51.88 ± 3.06)% and
(26.25 ± 1.79)%. With the extension of the inﬁltration time in
Table 1
Dose-dependent effects of zoledronic acid on SW480 cell survival rate.
Concentration of
ZOL (mmol/L)
Cell survival rate (%) Inhibition rate (%)
0 101.05 ± 3.03 0
12.5 64.23 ± 3.23⑴ 36.44
25 51.88 ± 3.06⑵ 48.66
50 44.81 ± 2.93⑶ 55.66
100 39.28 ± 2.67⑷ 61.13
200 30.24 ± 3.34⑸ 70.07
P 0.000 –
F 295.8 –
Compared with the ZOL group with a concentration of 0 mmoL/L: (1)
P = 0.000, q = 24.942, (2) P = 0.000, q = 34.254, (3) P = 0.000,
q = 40.029, (4) P = 0.000, q = 45.885, (5) P = 0.000, q = 47.106.
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decreased step by step, and the comparison differences had
distinctly statistical signiﬁcances (P < 0.01). The cell survival
rates of SW480 cells in the different inﬁltration time levels in
ZOL were signiﬁcantly lower than those of the untreated groups.
Also, the comparison differences had distinctly statistical sig-
niﬁcances (P < 0.01) (Table 2).
3.3. Comparison of cell survival rate, apoptosis rate,
△Jm and the expression quantity of cyt C in the
cytosol of the three groups
The detected cell survival rate, apoptosis rate,△Jm and the
expression quantity of cyt C in the cytosol of the control group
were considered as the reference standards. Compared with the
numerical values of the control group, the cell survival rate of
the ZOL group decreased signiﬁcantly accompanying with the
obvious increase of cell apoptosis rate and the expression
quantity of cyt C in the cytosol and the decrease of △Jm
meanwhile. The differences had distinctly statisticalTable 2
Time-dependent effects of zoledronic acid on SW480 cell survival rate.
Inﬁltrating time of ZOL (h) Cell survival rate (%) Inhibition rate (%)
0 100.83 ± 1.86 0
12 90.77 ± 2.82⑴ 9.98
24 73.38 ± 2.49⑵ 27.22
48 51.88 ± 3.06⑶ 48.55
72 26.25 ± 1.79⑷ 73.97
P 0.000 –
F 315.7 –
Compared with the group inﬁltrating in ZOL for 0 h: (1) P = 0.000,
q = 9.822, (2) P = 0.000, q = 27.461, (3) P = 0.000, q = 41.846, (4)
P = 0.000, q = 87.836.
Table 3
Comparison of cell survival rate, apoptosis rate,△Jm and the expression q
Groups Cell survival rate (%) Apoptos
Control group 100.05 ± 2.77 2.31 ±
ZOL group 53.24 ± 3.31⑴ 16.88 ±
CsA + ZOL group 81.92 ± 5.40⑸⑼ 9.33 ±
Compared with the control group: (1) P = 0.000, t = 32.536, (2) P = 0.000,
P = 0.000, t = 8.962, (6) P = 0.000, t = −11.654, (7) P = 0.000, t = 25.300, (8
t = −13.584, (10) P = 0.000, t = 9.627, (11) P = 0.000, t = −26.143, (12) Psigniﬁcances (P < 0.01). Although the cell survival rate of the
CsA + ZOL group was signiﬁcantly lower than that of the
control group, it went up again compared with the ZOL group;
its apoptosis rate and the expression quantity of cyt C in the
cytosol were higher than those of the control group but
accordingly lower than that of the ZOL group; △Jm of the
CsA + ZOL group was nearly 20% lower than that of the control
group, but compared with the ZOL group, it increased distinctly.
Also, The differences had distinctly statistical signiﬁcances
(P < 0.01) (Table 3).
4. Discussion
The statistical data of the International Agency for Research
on Cancer showed that 1.4 million new cases of colorectal
cancer were found only in 2012 in the world which accounted
for 9.7% of the total number of patients diagnosed with cancer in
that year. Colorectal cancer has already become the third com-
mon cancer in the whole world [7,8]. Although colorectal cancer
is prevailing mostly in Europe and the United States, its
morbidity and mortality rates have been increasing swiftly in
China, especially colon cancer. The morbidity of colon cancer
is signiﬁcantly higher than that of the colorectal cancer [9].
Scholars predicted that the morbidity of colon cancer in 2015
would be doubled as compared to that in 2002, which would
increase to 13% [10]. Confronting with the menacing disease, it
is greatly signiﬁcant and just around the corner to explore
effective treatment methods.
Among those several bisphosphonates drugs in clinic, ZOL is
given high attentions because of its strong efﬁcacy and persis-
tence. Besides, its performance in the treatment of cancer is also
the greatest. In vitro experimental results showed that inﬁltration
of 20 mmoL/L of ZOL could decrease the cell survival rate of
MDA-MB-231 of breast cancer by 75%, which is the three times
effect of pamidronate of the same concentration and 100 mmoL/
L of ﬂexor chloride sodium phosphate could show such anti-
cancer activity. In addition, ZOL under the concentration of
100 mmoL/L has no side effects on normal ﬁbroblasts [11]. This
study showed that ZOL also has anti-proliferation effect on
human colon cancer line SW480. Besides, the inhibition rate
increases with the increase of inﬁltrating concentration and the
extension of action time. Previous researches indicated that ZOL
could prevent the isoprene from synthesis by reducing the ac-
tivity of farnesyl diphosphate synthase. As a result, the modiﬁ-
cation and maturation of small G protein lack of its necessary
material, which causes the transmission failure of the cell
membrane channel signal and then cancer cell would lost their
activity and even die [12].
Apoptosis is a kind of rigorous and orderly ‘suicide’ which is
adopted autonomously when the body confronts adverse con-
ditions. Researches pointed that mitochondria play an importantuantity of cyt C in the cytosol of the three groups.
is rate (%) △Jm (%) Cyt C (%)
1.19 98.95 ± 2.06 100.01 ± 1.84
1.92⑵ 40.52 ± 3.57⑶ 162.52 ± 4.22⑷
1.36⑹⑽ 80.22 ± 2.83⑺⑾ 137.51 ± 3.15⑻⑿
t = −19.350, (3) P = 0.000, t = 42.528, (4) P = 0.000, t = −40.735, (5)
) P = 0.000, t = −30.839; Compared with the ZOL group: (9) P = 0.000,
= 0.000, t = 14.248.
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the cells may hasten the death of the cells [13,14]. In this study,
after treated with 25 mmoL/L of ZOL for 48 h, the cell
survival rate of SW480 decreased to (53.24 ± 3.31)%; the
apoptosis rate increased; △Jm decreased sharply and the
content of cyt C increased signiﬁcantly. All those indicated
that the abnormal opening of the mitochondrial permeability
transition (PT) pore which induces the apoptosis is closely
related to the inhibition effects of ZOL on SW480 cells. PT
pore penetrates the double membrane of the mitochondria.
Under the normal state, it could limit the penetration of
macromolecular substances. And cyt C protein is kept out of
the gap of the internal and external mitochondria membranes
and maintains the stable physiological potential difference of
the internal and external mitochondria membranes, which is
very important to the mitochondrial capacity [15]. It is
predicted that ZOL destroys the mitochondrial membrane
function structure of SW480. As a result, the PT pore opens
abnormally and cyt C protein gushes into the cytoplasm,
which causes the direct increase of the expression quantity of
cyt C in the cytosol. And these cyt C is the exact cause for
cell apoptosis by activating Caspase-series protease of cyto-
plasm [16,17]. At the same time, since the proton condition of the
both sides of the membrane is broken, △Jm decreases
disorderly and the composition of ATP is forced to stop. Cells
enter their energy depletion countdown. In the control group,
although SW480 cells pretreated with Mitochondrial PT pore
blocking agent CsA and inﬁltrated with ZOL still show a
serious of apoptosis phenomena which are mediated by
mitochondria and growth inhibition, it goes up again as
compared to the △Jm group. The content of cyt C in the
cytosol decreases and the apoptosis rate improves distinctly.
All these further conﬁrm the prediction that ZOL triggers the
damage of the mitochondrial membrane and induces the
apoptosis of SW480, while the speciﬁc truncation effect of
CsA on the opening of PT pore can effectively put off the
collapse of the mitochondria and the growth inhibition of cells.
In addition, it also appeared in the experience of breast cancer
and osteosarcoma cell that ZOL could facilitate the apoptosis of
the cancer cells, but it was revealed in the experience targeting
of mouse pulmonary adenocarcinoma and human chol-
angiocarcinoma cell that though ZOL inhibits the proliferation
of cells, it did not induce apoptosis [18,19], which indicated that
ZOL had more than one kind of anti-cancer mechanism. Li et al.
reported that ZOL could delay cell proliferation by preventing
lung cancer cells from entering the G2-M period [20].
In conclusion, ZOL can facilitate the apoptosis in human
colon cancer line SW480 and then inhibit the proliferation of
SW480 cells directly by opening the mitochondrial permeability
transition pore abnormally, decreasing△Jm, and releasing the
cyt C into the cytosol. Further in-depth explorations may
hopefully make ZOL a winning weapon in the battle of the
treatment of colorectal cancer.
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